SEC Form 4 · accession 0000805928-26-000089
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan M Levine
Director
Period of report
Jun 24, 2026
Accepted (ET)
Jun 26, 2026 · 4:52 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000805928
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jun 24, 2026 | A | 4,392 | A | — | — | Common Stock | 4,392 | 4,392 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- F2Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date.